alexa Cefixime, in General, Class 4 Drug but Individually Class 2 Drug | OMICS International| Abstract

Journal of Medical Physiology & Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Medical Physiology Therapeutics,

Cefixime, in General, Class 4 Drug but Individually Class 2 Drug

Poonam Mogal* and Deeliprao Derle
M.V.P.S’College of Pharmacy, , Nashik-2, Maharashtra, India
*Corresponding Author : Poonam Mogal, M.V.P.S’College of pharmacy, Nashik-2, Maharashtra, India, Tel: 09590929155, Email: [email protected]

Received Date: Apr 20, 2017 / Accepted Date: Apr 27, 2017 / Published Date: Feb 05, 2017

Abstract

Poor oral bioavailability of BCS class 4 drug is due to poor aqueous solubility and poor permeability across intestine. Present work was undertaken to increase oral bioavailability of BCS class 4 drug i.e. Cefixime using P-glycoprotein inhibitor hydrophile i.e. Pluronic and complexing agent beta cyclodextrin.

Comparative study was carried out using Pluronic as solid dispersion and beta cyclodextrin as inclusion complexation in different drug to polymer ratios through physical mix, kneading, solvent evaporation and spray drying technique. Physicochemical characterisation was done using saturated solubility studies, in vitro dissolution, ATR, DSC, SEM, and XRD study.

Prepared formulations were also evaluated for % drug permeation using non-everted rat intestinal sac method which showed that Pluronic was not involved in permeability enhancement of Cefixime.

Solid dispersion prepared with Pluronic found to show marked increment in solubility and dissolution as well as in ex-vivo permeation study.

In vivo study was carried out using Pluronic sd in male Wister rats (n=6) and which showed enhanced absorption of Cefixime with AUC 1.9 times greater than of the aqueous plain Cefixime suspension. Thus, BCS class 4 Cefixime can be treated as bcs class 2 by increasing its solubility instead of permeability as evident by ex-vivo and in vivo study.

Keywords: Cefixime; Pluronic; Cyclodextrin; Permeability; Solubility; Dissolution

Citation: Mogal P, Derle D (2017) Cefixime, in General, Class 4 Drug but Individually Class 2 Drug. J Med Physiol Ther 1:103.

Copyright: © 2017 Mogal P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 3389
  • [From(publication date): 0-2017 - Jan 23, 2020]
  • Breakdown by view type
  • HTML page views: 3181
  • PDF downloads: 208
Top